Vinay Prasad

Dr. Vinay Prasad is a former vaccine chief at the Food and Drug Administration (FDA). He is newsworthy due to his recent departure from the FDA, his second in less than a year. This departure follows controversies surrounding vaccine reviews and approvals, particularly concerning Moderna's new mRNA flu vaccine application, which the FDA initially declined to review. Prasad's tenure was marked by increased scrutiny of vaccine safety and effectiveness, including stricter protocols for vaccine approvals, which some experts have criticized as 'dangerous and irresponsible.' His departure contributes to the ongoing turmoil within the FDA, particularly at a time when the agency is facing criticism for its handling of vaccine approvals and effectiveness reviews, leading to external organizations stepping in to fill the perceived void. The situation highlights the political pressure and internal conflict impacting the FDA's regulatory processes.